24 May 2013
Keywords: biotech, holdings, v-411, diabetes, canada, begin, sales
Article | 08 April 1996
Biotech Holdings of Canada will begin sales in China of its
recently-approved Type II diabetes drug, V-411, in May. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 April 1996
15 April 1996
23 May 2013
© 2013 thepharmaletter.com